123 related articles for article (PubMed ID: 34971932)
1. Generation of a B2M homozygous knockout human somatic cell nuclear transfer-derived embryonic stem cell line using the CRISPR/Cas9 system.
Lee OH; Lee S; Park M; Moon S; Hwang S; Kim B; Kim CY; Lee DR; Shim SH; Park KH; Chung HM; Choi Y
Stem Cell Res; 2022 Mar; 59():102643. PubMed ID: 34971932
[TBL] [Abstract][Full Text] [Related]
2. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
3. Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing.
Bogomiakova ME; Sekretova EK; Eremeev AV; Shuvalova LD; Bobrovsky PA; Zerkalenkova EA; Lebedeva OS; Lagarkova MA
Stem Cell Res; 2021 Aug; 55():102451. PubMed ID: 34237591
[TBL] [Abstract][Full Text] [Related]
4. Generation of Mesenchymal Stromal Cells with Low Immunogenicity from Human PBMC-Derived β2 Microglobulin Knockout Induced Pluripotent Stem Cells.
Zha S; Tay JC; Zhu S; Li Z; Du Z; Wang S
Cell Transplant; 2020; 29():963689720965529. PubMed ID: 33172291
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy.
Meshitsuka S; Ninomiya R; Nagamura-Inoue T; Okada T; Futami M; Tojo A
Regen Ther; 2022 Dec; 21():442-452. PubMed ID: 36313397
[TBL] [Abstract][Full Text] [Related]
6. T-Cell Mediated Immune Rejection of Beta-2-Microglobulin Knockout Induced Pluripotent Stem Cell-Derived Kidney Organoids.
Gaykema LH; van Nieuwland RY; Lievers E; Moerkerk WBJ; de Klerk JA; Dumas SJ; Kers J; Zaldumbide A; van den Berg CW; Rabelink TJ
Stem Cells Transl Med; 2024 Jan; 13(1):69-82. PubMed ID: 37843402
[TBL] [Abstract][Full Text] [Related]
7. Knockout of beta-2 microglobulin enhances cardiac repair by modulating exosome imprinting and inhibiting stem cell-induced immune rejection.
Shao L; Zhang Y; Pan X; Liu B; Liang C; Zhang Y; Wang Y; Yan B; Xie W; Sun Y; Shen Z; Yu XY; Li Y
Cell Mol Life Sci; 2020 Mar; 77(5):937-952. PubMed ID: 31312880
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 Ribonucleoprotein Complex-Mediated Efficient B2M Knockout in Human Induced Pluripotent Stem Cells (iPSCs).
Thongsin N; Wattanapanitch M
Methods Mol Biol; 2022; 2454():607-624. PubMed ID: 33945142
[TBL] [Abstract][Full Text] [Related]
9. Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells.
Song C; Wang L; Li Q; Liao B; Qiao W; Li Q; Dong N; Li L
Stem Cell Res Ther; 2022 Feb; 13(1):48. PubMed ID: 35109922
[TBL] [Abstract][Full Text] [Related]
10. Generation of B2M bi-allelic knockout human induced pluripotent stem cells (MUSIi001-A-1) using a CRISPR/Cas9 system.
Thongsin N; Wattanapanitch M
Stem Cell Res; 2021 Oct; 56():102551. PubMed ID: 34628247
[TBL] [Abstract][Full Text] [Related]
11. Generation of Monkey Induced Pluripotent Stem Cell-Derived Cartilage Lacking Major Histocompatibility Complex Class I Molecules on the Cell Surface.
Okutani Y; Abe K; Yamashita A; Morioka M; Matsuda S; Tsumaki N
Tissue Eng Part A; 2022 Jan; 28(1-2):94-106. PubMed ID: 34182799
[TBL] [Abstract][Full Text] [Related]
12. Human Leukocyte Antigen Class I and II Knockout Human Induced Pluripotent Stem Cell-Derived Cells: Universal Donor for Cell Therapy.
Mattapally S; Pawlik KM; Fast VG; Zumaquero E; Lund FE; Randall TD; Townes TM; Zhang J
J Am Heart Assoc; 2018 Dec; 7(23):e010239. PubMed ID: 30488760
[TBL] [Abstract][Full Text] [Related]
13. HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications.
Karabekian Z; Ding H; Stybayeva G; Ivanova I; Muselimyan N; Haque A; Toma I; Posnack NG; Revzin A; Leitenberg D; Laflamme MA; Sarvazyan N
Tissue Eng Part A; 2015 Oct; 21(19-20):2559-71. PubMed ID: 26218149
[TBL] [Abstract][Full Text] [Related]
14. Universal Corneal Epithelial-Like Cells Derived from Human Embryonic Stem Cells for Cellularization of a Corneal Scaffold.
Yang J; Park JW; Zheng D; Xu RH
Transl Vis Sci Technol; 2018 Sep; 7(5):23. PubMed ID: 30323996
[TBL] [Abstract][Full Text] [Related]
15. HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for "Off-the-Shelf" Immunotherapy.
Hoerster K; Uhrberg M; Wiek C; Horn PA; Hanenberg H; Heinrichs S
Front Immunol; 2020; 11():586168. PubMed ID: 33584651
[TBL] [Abstract][Full Text] [Related]
16. Generation of Retinal Pigment Epithelial Cells Derived from Human Embryonic Stem Cells Lacking Human Leukocyte Antigen Class I and II.
Petrus-Reurer S; Winblad N; Kumar P; Gorchs L; Chrobok M; Wagner AK; Bartuma H; Lardner E; Aronsson M; Plaza Reyes Á; André H; Alici E; Kaipe H; Kvanta A; Lanner F
Stem Cell Reports; 2020 Apr; 14(4):648-662. PubMed ID: 32197113
[TBL] [Abstract][Full Text] [Related]
17. HLA engineering of human pluripotent stem cells.
Riolobos L; Hirata RK; Turtle CJ; Wang PR; Gornalusse GG; Zavajlevski M; Riddell SR; Russell DW
Mol Ther; 2013 Jun; 21(6):1232-41. PubMed ID: 23629003
[TBL] [Abstract][Full Text] [Related]
18. Comparing the Benefits and Drawbacks of Stem Cell Therapy Based on the Cell Origin or Manipulation Process: Addressing Immunogenicity.
Chang SH; Park CG
Immune Netw; 2023 Dec; 23(6):e44. PubMed ID: 38188600
[TBL] [Abstract][Full Text] [Related]
19. Beta-2 microglobulin knockout K562 cell-based artificial antigen presenting cells for
Zha S; Li Z; Chen C; Du Z; Tay JC; Wang S
Immunotherapy; 2019 Aug; 11(11):967-982. PubMed ID: 31218907
[No Abstract] [Full Text] [Related]
20. Expression of Major Histocompatibility Complex during Neuronal Differentiation of Somatic Cell Nuclear Transfer-Human Embryonic Stem Cells.
Lee JS; Lee JE; Yu SH; Chun T; Chang MY; Lee DR; Park CH
Int J Stem Cells; 2024 Feb; 17(1):59-69. PubMed ID: 37879852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
